Modeling and Simulation Archives | Certara

Blog

Model-Based Meta-Analysis (MBMA) at GSK: Real-World Impact on Strategy and Trials

GSK shares real-world case studies on how Model-Based Meta-Analysis (MBMA) supports dose selection, virtual control…

CertaraJuly 31, 2025

Webinar

Certara’s Simcyp Educational Webinar Series Part 4: Changes in Drug Absorption after Meals and the Reality of Prediction Using Modeling Approaches [in Japanese]

CertaraJuly 30, 2025

Blog

Recapping a record-breaking 2025 Krakow HTA Symposium

We cover the key takeaways from CERTAINTY 2025, including the power of Model-Informed Drug Development…

Simona ColucciJuly 30, 2025

Case Study

Optimizing Dosing and Regulatory Outcomes in Duchenne Muscular Dystrophy (DMD) Drug Development

Certara supported DMD drug development for Givinostat, helping Italfarmaco with pharmacometric and regulatory strategy.

CertaraJuly 29, 2025

Conference

AusBiotech International Conference 2025

Danielle PillsburyJuly 25, 2025

Conference

JSSX 2025 in Japan

Danielle PillsburyJuly 25, 2025

Conference

AAPS 2025 PharmSci 360

CertaraJuly 24, 2025

Blog

ADNCA Explained: The Next Generation of Non-Compartmental Analysis and the Top Questions Answered

ADNCA is transforming non-compartmental analysis by standardizing workflows, enhancing regulatory confidence, and enabling scalable automation.…

CertaraJuly 23, 2025

Press Coverage

The end of animal testing? Transitioning to models is promising — but no silver bullet

The FDA has stated that the pharma industry must transition to using in vitro assays,…

CertaraJuly 21, 2025

Webinar

Certara’s Simcyp Educational Webinar Series Part 3: Understanding the Supersaturated Dissolution in the Digestive Tract with Modeling & Simulation Approaches [in Japanese]

CertaraJuly 16, 2025

© 2025 Certara. All Rights Reserved. | Privacy policy